{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T13:35:30Z","timestamp":1789392930881,"version":"build-2803163510"},"reference-count":13,"publisher":"Hindawi Limited","issue":"4","license":[{"start":{"date-parts":[[2015,5,26]],"date-time":"2015-05-26T00:00:00Z","timestamp":1432598400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2015,5,26]],"date-time":"2015-05-26T00:00:00Z","timestamp":1432598400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pharm Ther"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1111\/jcpt.12288","type":"journal-article","created":{"date-parts":[[2015,5,26]],"date-time":"2015-05-26T13:28:01Z","timestamp":1432646881000},"page":"447-451","source":"Crossref","is-referenced-by-count":30,"title":["Evaluation of the appropriateness of dosing, indication and safety of rivaroxaban in a community hospital"],"prefix":"10.1155","volume":"40","author":[{"given":"K. B.","family":"Tellor","sequence":"first","affiliation":[{"name":"St. Louis College of Pharmacy; St. Louis MO USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Patel","sequence":"additional","affiliation":[{"name":"St. Louis College of Pharmacy; St. Louis MO USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. L.","family":"Armbruster","sequence":"additional","affiliation":[{"name":"St. Louis College of Pharmacy; St. Louis MO USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. W.","family":"Daly","sequence":"additional","affiliation":[{"name":"Saint Louis University Hospital; St. Louis MO USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"98","published-online":{"date-parts":[[2015,5,26]]},"reference":[{"key":"10.1111\/jcpt.12288-BIB0001|jcpt12288-cit-0001","unstructured":"Coumadin \u00ae [package insert] Princeton Bristol-Myers Squibb Company 2013"},{"key":"10.1111\/jcpt.12288-BIB0002|jcpt12288-cit-0002","doi-asserted-by":"publisher","first-page":"e44S","DOI":"10.1378\/chest.11-2292","article-title":"Oral anticoagulant therapy: antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Ageno","year":"2012","journal-title":"Chest"},{"key":"10.1111\/jcpt.12288-BIB0003|jcpt12288-cit-0003","unstructured":"FDA expands use of Xarelto to treat, reduce recurrence of blood clots http:\/\/www.fda.gov\/NewsEvents\/Newsroom\/"},{"key":"10.1111\/jcpt.12288-BIB0004|jcpt12288-cit-0004","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1111\/jcpt.12288-BIB0005|jcpt12288-cit-0005","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1056\/NEJMoa1113572","article-title":"Oral rivaroxaban for the treatment of symptomatic pulmonary embolism","volume":"366","author":"B\u00fcller","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1111\/jcpt.12288-BIB0006|jcpt12288-cit-0006","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1056\/NEJMoa1007903","article-title":"Oral rivaroxaban for symptomatic venous thromboembolism","volume":"363","author":"Bauersachs","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1111\/jcpt.12288-BIB0007|jcpt12288-cit-0007","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jacc.2014.03.022","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: A report of the American College of Cardiology\/American Heart Association task force on practice guidelines and the heart rhythm society","volume":"64","author":"January","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/jcpt.12288-BIB0008|jcpt12288-cit-0008","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1378\/chest.11-2301","article-title":"Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, 9th edition","volume":"141","author":"Kearon","year":"2012","journal-title":"Chest"},{"key":"10.1111\/jcpt.12288-BIB0009|jcpt12288-cit-0009","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"key":"10.1111\/jcpt.12288-BIB0010|jcpt12288-cit-0010","unstructured":"Xarelto \u00ae [package insert] Princeton Janssen Pharmaceuticals, Inc. 2014"},{"key":"10.1111\/jcpt.12288-BIB0011|jcpt12288-cit-0011","doi-asserted-by":"publisher","first-page":"e576S","DOI":"10.1378\/chest.11-2305","article-title":"Antithrombotic and thrombolytic therapy for valvular disease: antithrombotic Therapy and Prevention of Thrombosis, 9th ed: american College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Whitlock","year":"2012","journal-title":"Chest"},{"key":"10.1111\/jcpt.12288-BIB0012|jcpt12288-cit-0012","first-page":"376","article-title":"Evaluation of dabigatran for appropriate of use and bleeding events in a community hospital setting","volume":"7","author":"Armbruster","year":"2014","journal-title":"Am Health Drug Benefits"},{"key":"10.1111\/jcpt.12288-BIB0013|jcpt12288-cit-0013","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1592\/phco.2005.25.11.1666","article-title":"Guidelines for therapeutic interchange-2004","volume":"25","author":"Gray","year":"2005","journal-title":"Pharmacotherapy"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12288","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12288","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jcpt.12288\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:05:56Z","timestamp":1671818756000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jcpt.12288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,26]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,8]]}},"URL":"https:\/\/doi.org\/10.1111\/jcpt.12288","archive":["Portico"],"relation":{},"ISSN":["0269-4727"],"issn-type":[{"value":"0269-4727","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5,26]]}}}